IN2014DN01791A - - Google Patents
Info
- Publication number
- IN2014DN01791A IN2014DN01791A IN1791DEN2014A IN2014DN01791A IN 2014DN01791 A IN2014DN01791 A IN 2014DN01791A IN 1791DEN2014 A IN1791DEN2014 A IN 1791DEN2014A IN 2014DN01791 A IN2014DN01791 A IN 2014DN01791A
- Authority
- IN
- India
- Prior art keywords
- prevention
- treatment
- invention concerns
- receptor antagonists
- ampa receptor
- Prior art date
Links
- 229940098747 AMPA receptor antagonist Drugs 0.000 abstract 1
- 239000000775 AMPA receptor antagonist Substances 0.000 abstract 1
- 230000002860 competitive effect Effects 0.000 abstract 1
- 201000003040 photosensitive epilepsy Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 201000005070 reflex epilepsy Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
- C07D239/96—Two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention concerns the use of competitive AMPA receptor antagonists for the treatment or prevention of photosensitive epilepsy.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/050687 WO2013036224A1 (en) | 2011-09-07 | 2011-09-07 | Use of 1h-quinazoline- 2, 4 -diones for use in the prevention or treatment photosensitive epilepsy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN01791A true IN2014DN01791A (en) | 2015-05-15 |
Family
ID=44652020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1791DEN2014 IN2014DN01791A (en) | 2011-09-07 | 2011-09-07 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2753331A1 (en) |
| JP (1) | JP2014525474A (en) |
| KR (1) | KR20140071405A (en) |
| CN (1) | CN103889427A (en) |
| AU (1) | AU2011376333A1 (en) |
| BR (1) | BR112014005210A2 (en) |
| CA (1) | CA2846503A1 (en) |
| IN (1) | IN2014DN01791A (en) |
| MX (1) | MX2014002693A (en) |
| WO (1) | WO2013036224A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW201609719A (en) * | 2014-05-28 | 2016-03-16 | 美國禮來大藥廠 | 6-substituted-3H-1,3-benzothiazol-2-one compounds as TARP-gamma 8 dependent AMPA receptor antagonists |
| JP6902033B2 (en) | 2015-12-30 | 2021-07-14 | アダマス ファーマシューティカルズ， インコーポレイテッド | Methods and compositions for the treatment of seizure-related disorders |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0128996D0 (en) | 2001-12-04 | 2002-01-23 | Novartis Ag | Organic compounds |
| SE0201943D0 (en) | 2002-06-20 | 2002-06-20 | Astrazeneca Ab | New use |
| EP1677788A1 (en) | 2003-10-31 | 2006-07-12 | AstraZeneca AB | Alkynes iii |
| JP2007510645A (en) | 2003-10-31 | 2007-04-26 | アストラゼネカ アクチボラグ | Alkynes I |
| JP2007509935A (en) | 2003-10-31 | 2007-04-19 | アストラゼネカ アクチボラグ | Alkins II |
| EP1715867A4 (en) | 2004-02-12 | 2009-04-15 | Merck & Co Inc | BIPYRIDYL AMIDES AS MODULATORS OF GLUTAMATE METABOTROPIC REPEATER-5 |
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
| GB0508319D0 (en) | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| JP2009519986A (en) | 2005-12-20 | 2009-05-21 | ノバルティス アクチエンゲゼルシャフト | Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| US10786464B2 (en) * | 2009-11-03 | 2020-09-29 | Lupin Limited | Modified release formulation of lacosamide |
-
2011
- 2011-09-07 KR KR1020147008752A patent/KR20140071405A/en not_active Withdrawn
- 2011-09-07 WO PCT/US2011/050687 patent/WO2013036224A1/en not_active Ceased
- 2011-09-07 AU AU2011376333A patent/AU2011376333A1/en not_active Abandoned
- 2011-09-07 MX MX2014002693A patent/MX2014002693A/en not_active Application Discontinuation
- 2011-09-07 BR BR112014005210A patent/BR112014005210A2/en not_active IP Right Cessation
- 2011-09-07 CA CA2846503A patent/CA2846503A1/en not_active Abandoned
- 2011-09-07 EP EP11757513.4A patent/EP2753331A1/en not_active Withdrawn
- 2011-09-07 JP JP2014529647A patent/JP2014525474A/en not_active Withdrawn
- 2011-09-07 IN IN1791DEN2014 patent/IN2014DN01791A/en unknown
- 2011-09-07 CN CN201180073318.7A patent/CN103889427A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN103889427A (en) | 2014-06-25 |
| BR112014005210A2 (en) | 2017-03-21 |
| AU2011376333A1 (en) | 2014-03-13 |
| EP2753331A1 (en) | 2014-07-16 |
| CA2846503A1 (en) | 2013-03-14 |
| WO2013036224A1 (en) | 2013-03-14 |
| MX2014002693A (en) | 2014-06-04 |
| KR20140071405A (en) | 2014-06-11 |
| JP2014525474A (en) | 2014-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS2000032I1 (en) | Substituted 4-phenylpyridines for the treatment of NK-1 receptor related diseases | |
| GB201017345D0 (en) | Receptor antagonists | |
| CR20140229A (en) | NEW BICYCLIC DERIVATIVES OF DIHIDROISOQUINOLIN-1-ONA | |
| UA116196C2 (en) | Synthetic apelin mimetics for the treatment of heart failure | |
| IL253197A0 (en) | Methods of treating conditions related to the s1p1 receptor | |
| MX370253B (en) | Compositions of jasmonate compounds and methods of use. | |
| HUE047410T2 (en) | Analogues of 4h-pyrazolo[1,5- ]benzimidazole compound as parp inhibitors | |
| PL2763527T3 (en) | Method for the fungicidal treatment of resistant strains using one or more essential oils | |
| FR2979931B1 (en) | POTELET OF GARDE-BODY OR SCAFFOLD EQUIPPED OF AN IMPROVED BLOCKER | |
| PL2807170T3 (en) | Phragmalin limonoids for the treatment of sexual dysfunction | |
| HUE045270T2 (en) | Flt3 receptor antagonists for the treatment or the prevention of pain disorders | |
| PH12018500282A1 (en) | Cgrp receptor antagonists | |
| EP2771346A4 (en) | OXINOLINE RECEPTOR ANTAGONISTS OF THE ISOXAZOLOPYRIDINE TYPE | |
| IN2014KN02993A (en) | ||
| AP2012006630A0 (en) | Disubstituted tetrahydofuranyl compounds as antagonists of the bradykinin B1 receptor | |
| IN2014DN00254A (en) | ||
| IN2014DN01791A (en) | ||
| GB2499487B (en) | Floating-point of the invention | |
| SG10201403562UA (en) | Implant for the treatment or prevention of an aneurysm | |
| GB201012359D0 (en) | Invention 6.5.10 | |
| WO2013130501A8 (en) | Bivalent ampa receptor positive allosteric modulators | |
| FR2996871B1 (en) | DEVICE FOR CORRECTING THE BEND OF A FLOOR SLAB | |
| IN2012DN00235A (en) | ||
| GB201015621D0 (en) | Invention 30.08.10 | |
| MX2015001134A (en) | Therapeutic compounds. |